help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burger, H. G.
Right arrow Articles by Dennerstein, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burger, H. G.
Right arrow Articles by Dennerstein, L.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 11 4025-4030
Copyright © 1999 by The Endocrine Society

Original Studies

Prospectively Measured Levels of Serum Follicle-Stimulating Hormone, Estradiol, and the Dimeric Inhibins during the Menopausal Transition in a Population-Based Cohort of Women1

Henry G. Burger, Emma C. Dudley, John L. Hopper, Nigel Groome, Janet R. Guthrie, Adele Green and Lorraine Dennerstein

Prince Henry’s Institute of Medical Research (H.G.B.), Monash Medical Centre, Victoria 3168, Australia; The Office for Gender and Health (E.C.D., J.R.G., L.D.) and Department of General Practice and Public Health (J.L.H.), The University of Melbourne, Melbourne 3050, Australia; Oxford Brookes University (N.G.), Oxford OX3 OBP, United Kingdom; and Queensland Institute of Medical Research (A.G.), Brisbane 4029, Queensland

Address correspondence and requests for reprints to: Prof. H.G. Burger, Prince Henry’s Institute of Medical Research, Level 4, Block E, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia. E-mail: henry.burger{at}med.monash.edu.au

The aims of this study were: 1) to describe, in relation to the date of final menses, the average hormone levels of women in the years before and after this date and to determine the extent to which these average levels were dependent on age and body mass index (BMI); and 2) to determine the degree of tracking in residual hormone levels [i.e., the extent to which individuals above (below) the mean for their age or time relative to final menstrual period (FMP) and BMI remain above (below) the mean as time progresses]. Serial levels of serum FSH, circulating estradiol (E2), and the dimeric inhibins (INH) A and B were measured annually in 150 women who experienced a natural menopause during 6 years of follow-up. Means of the log-transformed hormonal levels were analyzed as a double-logistic function of time relative to FMP, as well as age and BMI and correlations between repeated hormonal levels, were measured. Mean FSH levels started to increase from about 2 years before the FMP, increased most rapidly about 10 months before the FMP, and had virtually plateaued by 2 years after the FMP. FSH levels were, on average, 3% greater for each year of age and 2% lower for each kg/m2 of BMI. After adjusting for time relative to the FMP, logFSH showed modest tracking. Age-adjusted values of logFSH were moderately correlated across time, and much of this tracking was explained by the actual timing of a woman’s FMP. Mean E2 levels started to decrease about 2 years before the FMP, decreased most rapidly around the time of the FMP, and had virtually plateaued by 2 years after the FMP. E2 levels were lower, on average, by about 9% per year of age, and residual values showed weak tracking. Levels of both INHA and INHB decreased, on average, in the years before the FMP and were undetectable (INHA, <10 pg/mL; INHB, < 25 pg/mL) in the majority of women by the time of the FMP and in almost all women by 4 years post-FMP. Significant negative correlations between log serum FSH and log E2 (r = -0.73) and log INHA (r = -0.41) and log INHB (r = -0.36) were observed. It is concluded that substantial changes in reproductive hormone levels occur within 1–2 yr on each side of the FMP, that falling concentrations of E2 and the INH contribute to the rising concentrations of FSH, and that there is no single reliable hormonal marker of menopausal status for an individual woman.




This article has been cited by other articles:


Home page
 Hum ReprodHome page
C. Gnoth, A.N. Schuring, K. Friol, J. Tigges, P. Mallmann, and E. Godehardt
Relevance of anti-Mullerian hormone measurement in a routine IVF program
Hum. Reprod., June 1, 2008; 23(6): 1359 - 1365.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Santoro, S. L. Crawford, W. L. Lasley, J. L. Luborsky, K. A. Matthews, D. McConnell, J. F. Randolph Jr., E. B. Gold, G. A. Greendale, S. G. Korenman, et al.
Factors Related to Declining Luteal Function in Women during the Menopausal Transition
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1711 - 1721.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
C. Tatone, F. Amicarelli, M. C. Carbone, P. Monteleone, D. Caserta, R. Marci, P. G. Artini, P. Piomboni, and R. Focarelli
Cellular and molecular aspects of ovarian follicle ageing
Hum. Reprod. Update, March 1, 2008; 14(2): 131 - 142.
[Abstract] [Full Text] [PDF]

Home page
 Am J Health Syst PharmHome page
K. L. Scolaro, K. B. Lloyd, and K. L. Helms
Devices for home evaluation of women's health concerns
Am. J. Health Syst. Pharm., February 15, 2008; 65(4): 299 - 314.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
L. Dennerstein, P. Lehert, H. G. Burger, and J. R. Guthrie
New findings from non-linear longitudinal modelling of menopausal hormone changes
Hum. Reprod. Update, November 1, 2007; 13(6): 551 - 557.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
H.G. Burger, G.E. Hale, D.M. Robertson, and L. Dennerstein
A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women's Midlife Health Project
Hum. Reprod. Update, November 1, 2007; 13(6): 559 - 565.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. D. van Beek, M. M. van den Heuvel-Eibrink, J. S. E. Laven, F. H. de Jong, A. P. N. Themmen, F. G. Hakvoort-Cammel, C. van den Bos, H. van den Berg, R. Pieters, and S. M. P. F. de Muinck Keizer-Schrama
Anti-Mullerian Hormone Is a Sensitive Serum Marker for Gonadal Function in Women Treated for Hodgkin's Lymphoma during Childhood
J. Clin. Endocrinol. Metab., October 1, 2007; 92(10): 3869 - 3874.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
E. W. Freeman, M. D. Sammel, H. Lin, C. R. Gracia, G. W. Pien, D. B. Nelson, and L. Sheng
Symptoms Associated With Menopausal Transition and Reproductive Hormones in Midlife Women
Obstet. Gynecol., August 1, 2007; 110(2): 230 - 240.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Tsigkou, D. Marrelli, F. M. Reis, S. Luisi, A. L. Silva-Filho, F. Roviello, S. A. Triginelli, and F. Petraglia
Total Inhibin Is a Potential Serum Marker for Epithelial Ovarian Cancer
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2526 - 2531.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. F. Randolph Jr., S. Crawford, L. Dennerstein, K. Cain, S. D. Harlow, R. Little, E. S. Mitchell, B. Nan, J. Taffe, and M. Yosef
The Value of Follicle-Stimulating Hormone Concentration and Clinical Findings as Markers of the Late Menopausal Transition
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 3034 - 3040.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
M. E. Kevenaar, M. F. Meerasahib, P. Kramer, B. M. N. van de Lang-Born, F. H. de Jong, N. P. Groome, A. P. N. Themmen, and J. A. Visser
Serum Anti-Mullerian Hormone Levels Reflect the Size of the Primordial Follicle Pool in Mice
Endocrinology, July 1, 2006; 147(7): 3228 - 3234.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
H. S. Kok, K. M. van Asselt, Y. T. van der Schouw, I. van der Tweel, P. H.M. Peeters, P. W.F. Wilson, P. L. Pearson, and D. E. Grobbee
Heart Disease Risk Determines Menopausal Age Rather Than the Reverse
J. Am. Coll. Cardiol., May 16, 2006; 47(10): 1976 - 1983.
[Abstract] [Full Text] [PDF]

Home page
 ReproductionHome page
J. A Visser, F. H de Jong, J. S E Laven, and A. P N Themmen
Anti-Mullerian hormone: a new marker for ovarian function
Reproduction, January 1, 2006; 131(1): 1 - 9.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. F. Randolph Jr, M. Sowers, I. Bondarenko, E. B. Gold, G. A. Greendale, J. T. Bromberger, S. E. Brockwell, and K. A. Matthews
The Relationship of Longitudinal Change in Reproductive Hormones and Vasomotor Symptoms during the Menopausal Transition
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6106 - 6112.
[Abstract] [Full Text] [PDF]

Home page
 Reproductive SciencesHome page
A. La Marca, V. De Leo, S. Giulini, R. Orvieto, S. Malmusi, L. Giannella, and A. Volpe
Anti-Mullerian Hormone in Premenopausal Women and After Spontaneous or Surgically Induced Menopause
Reproductive Sciences, October 1, 2005; 12(7): 545 - 548.
[Abstract] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Y. Liu, K. A. Hoey, K. L. Mielke, J. D. Veldhuis, and S. Khosla
A Randomized Placebo-Controlled Trial of Short-Term Graded Transdermal Estradiol in Healthy Gonadotropin-Releasing Hormone Agonist-Suppressed Pre- and Postmenopausal Women: Effects on Serum Markers of Bone Turnover, Insulin-Like Growth Factor-I, and Osteoclastogenic Mediators
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1953 - 1960.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. K. Welt, J. E. Hall, J. M. Adams, and A. E. Taylor
Relationship of Estradiol and Inhibin to the Follicle-Stimulating Hormone Variability in Hypergonadotropic Hypogonadism or Premature Ovarian Failure
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 826 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. R. Hansen, A. C. Thyer, P. M. Sluss, W. J. Bremner, M. R. Soules, and N. A. Klein
Reproductive ageing and ovarian function: is the early follicular phase FSH rise necessary to maintain adequate secretory function in older ovulatory women?
Hum. Reprod., January 1, 2005; 20(1): 89 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
K. Lutchman Singh, M. Davies, and R. Chatterjee
Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing
Hum. Reprod. Update, January 1, 2005; 11(1): 69 - 89.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Bjornerem, B. Straume, M. Midtby, V. Fonnebo, J. Sundsfjord, J. Svartberg, G. Acharya, P. Oian, and G. K. R. Berntsen
Endogenous Sex Hormones in Relation to Age, Sex, Lifestyle Factors, and Chronic Diseases in a General Population: The Tromso Study
J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6039 - 6047.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. Miro, S. W. Parker, L. J. Aspinall, J. Coley, P. W. Perry, and J. E. Ellis
Relationship between Follicle-Stimulating Hormone Levels at the Beginning of the Human Menstrual Cycle, Length of the Follicular Phase and Excreted Estrogens: The FREEDOM Study
J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3270 - 3275.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Santoro, B. Lasley, D. McConnell, J. Allsworth, S. Crawford, E. B. Gold, J. S. Finkelstein, G. A. Greendale, J. Kelsey, S. Korenman, et al.
Body Size and Ethnicity Are Associated with Menstrual Cycle Alterations in Women in the Early Menopausal Transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2622 - 2631.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
B.-M. Landgren, A. Collins, G. Csemiczky, H. G. Burger, L. Baksheev, and D. M. Robertson
Menopause Transition: Annual Changes in Serum Hormonal Patterns over the Menstrual Cycle in Women during a Nine-Year Period Prior to Menopause
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2763 - 2769.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. A. Klein, B. S. Houmard, K. R. Hansen, T. K. Woodruff, P. M. Sluss, W. J. Bremner, and M. R. Soules
Age-Related Analysis of Inhibin A, Inhibin B, and Activin A Relative to the Intercycle Monotropic Follicle-Stimulating Hormone Rise in Normal Ovulatory Women
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2977 - 2981.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. F. Randolph Jr., M. Sowers, I. V. Bondarenko, S. D. Harlow, J. L. Luborsky, and R. J. Little
Change in Estradiol and Follicle-Stimulating Hormone across the Early Menopausal Transition: Effects of Ethnicity and Age
J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1555 - 1561.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Halmesmaki, R. Hurskainen, A. Tiitinen, J. Teperi, S. Grenman, A. Kivela, E. Kujansuu, M. Yliskoski, and J. Paavonen
A randomized controlled trial of hysterectomy or levonorgestrel-releasing intrauterine system in the treatment of menorrhagia--effect on FSH levels and menopausal symptoms
Hum. Reprod., February 1, 2004; 19(2): 378 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. Santoro, B. Isaac, G. Neal-Perry, T. Adel, L. Weingart, A. Nussbaum, S. Thakur, H. Jinnai, N. Khosla, and D. Barad
Impaired Folliculogenesis and Ovulation in Older Reproductive Aged Women
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5502 - 5509.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
L. S. Cohen, C. N. Soares, J. R. Poitras, J. Prouty, A. B. Alexander, and J. L. Shifren
Short-Term Use of Estradiol for Depression in Perimenopausal and Postmenopausal Women: A Preliminary Report
Am J Psychiatry, August 1, 2003; 160(8): 1519 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier
Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone
Endocr. Rev., April 1, 2003; 24(2): 152 - 182.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. F. Randolph Jr., M. Sowers, E. B. Gold, B. A. Mohr, J. Luborsky, N. Santoro, D. S. McConnell, J. S. Finkelstein, S. G. Korenman, K. A. Matthews, et al.
Reproductive Hormones in the Early Menopausal Transition: Relationship to Ethnicity, Body Size, and Menopausal Status
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1516 - 1522.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
N. A. Klein, A. J. Harper, B. S. Houmard, P. M. Sluss, and M. R. Soules
Is the Short Follicular Phase in Older Women Secondary to Advanced or Accelerated Dominant Follicle Development?
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5746 - 5750.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. E. Hale, C. L. Hughes, and J. M. Cline
Endometrial Cancer: Hormonal Factors, the Perimenopausal ""Window of Risk,"" and Isoflavones
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 3 - 15.
[Abstract] [Full Text] [PDF]

Home page
 Recent Prog Horm ResHome page
H. G. Burger, E. C. Dudley, D. M. Robertson, and L. Dennerstein
Hormonal Changes in the Menopause Transition
Recent Prog. Horm. Res., January 1, 2002; 57(1): 257 - 275.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
M. Sherburn, J. R. Guthrie, E. C. Dudley, H. E. O'Connell, and L. Dennerstein
Is Incontinence Associated With Menopause?
Obstet. Gynecol., October 1, 2001; 98(4): 628 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R. J. Norman, C. R. Milner, N. P. Groome, and D. M. Robertson
Circulating follistatin concentrations are higher and activin concentrations are lower in polycystic ovarian syndrome
Hum. Reprod., April 1, 2001; 16(4): 668 - 672.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
L. DENNERSTEIN, E. C. DUDLEY, J. L. HOPPER, J. R. GUTHRIE, and H. G. BURGER
A Prospective Population-Based Study of Menopausal Symptoms
Obstet. Gynecol., September 1, 2000; 96(3): 351 - 358.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. G. Burger, E. C. Dudley, J. Cui, L. Dennerstein, and J. L. Hopper
A Prospective Longitudinal Study of Serum Testosterone, Dehydroepiandrosterone Sulfate, and Sex Hormone-Binding Globulin Levels through the Menopause Transition
J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2832 - 2838.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society